Abcam, ab250662, Anti-ATF7 antibody [EPR13556] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal ATF7 antibody. Carrier free. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR13556,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat, Human,
Applications:WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab250662 is the carrier-free version of
ab183507
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
ATF7 (activating transcription factor 7) is a transcription factor that belongs to the ATF/CREB family. It has alternative names such as ATFa and B-ATF. Mechanically ATF7 regulates transcription by binding to cyclic AMP response elements (CRE) in DNA. This protein has a mass of approximately 55 kDa. ATF7 is expressed in various tissues throughout the body including the brain liver and spleen supporting its involvement in multiple physiological processes.
Biological function summary
ATF7 functions in cellular stress responses and cell differentiation. It often forms a complex with other transcription factors to exert its effects on gene expression. ATF7 is known to influence the expression of genes involved in stress response pathways and apoptosis. By regulating these genes ATF7 plays a role in how cells react to environmental changes and maintain homeostasis.
Pathways
ATF7 is involved in significant signaling pathways such as the MAPK and JNK pathways. These pathways are important for transmitting signals from the cell surface to the nucleus affecting gene expression. ATF7 interacts with proteins such as c-Jun and ATF2 within these pathways facilitating cellular responses to stress and growth signals.
ATF7 has been linked to certain cancers and neurodegenerative diseases. Abnormal expression or mutation of ATF7 can contribute to the progression of cancer possibly through its interaction with proteins like c-Myc. In neurodegenerative conditions ATF7 might play a role in neuronal cell death potentially in connection with proteins involved in stress signaling such as p53. Understanding the role of ATF7 in these disorders may provide insight into new therapeutic strategies.